Robert G. Shawah serves as Executive at Dipexium Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert G. Shawah has executed 1 insider transactions totaling $6.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 18, 2014 involved purchasing 500 shares valued at $6.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 18, 2014 | DPRX | $6.0K | Purchase | 500 | $12.00 | Discretionary |
Robert G. Shawah currently holds 500 shares of Dipexium Pharmaceuticals, Inc. (DPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert G. Shawah has been a net buyer of DPRX stock. They have purchased $6.0K and sold $0 worth of shares.
Robert G. Shawah's most recent insider trade was on Mar 18, 2014, when they purchased 500 shares at $12.00 per share.
Get notified when new Form 4 filings are submitted